Alexandria Real Estate Equities
ARE
#2088
Rank
S$11.97 B
Marketcap
S$69.31
Share price
-0.07%
Change (1 day)
-46.56%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Alexandria Real Estate Equities (ARE) Fails to deliver data

Key failure to deliver metrics for Alexandria Real Estate Equities :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Alexandria Real Estate Equities (ARE) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Alexandria Real Estate Equities (ARE) - since 2013

Volume in USD (price x number of shares), data since 2013

Alexandria Real Estate Equities (ARE) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025S$31.32 M-48.2%
2024S$60.47 M46.83%
2023S$41.18 M-64.08%
2022S$0.11 B22.18%
2021S$93.85 M-16.64%
2020S$0.11 B38.94%
2019S$81.03 M-10.89%
2018S$90.94 M-43.57%
2017S$0.16 B192.01%
2016S$55.19 M125.93%
2015S$24.42 M11.4%
2014S$21.92 M875.57%
2013S$2.24 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Pfizer
PFE
S$27.68 MS$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$35.08 MS$0.24 B๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$0.28 BS$0.42 B๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$6.06 MS$26.57 M๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$7.81 MS$0.21 B๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$23.42 MS$0.20 B๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$9.04 MS$42.05 M๐Ÿ‡บ๐Ÿ‡ธ USA